Floatz logo

Rimiducid

Hurler Syndrome

Small moleculeDormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

4 Active assets in the Hurler Syndrome cohort.

Asset / SponsorPhaseRating
Aldurazyme
Genzyme, a Sanofi Company
Phase 4A
IDURONIDASE, .ALPHA.-L-(8-HISTIDINE) (HUMAN)
Masonic Cancer Center, University of Minnesota
Phase 4BB
IDURONIDASE, .ALPHA.-L-(8-HISTIDINE) (HUMAN)
Masonic Cancer Center, University of Minnesota
Phase 4BB
Thiotepa
University of Florida
Phase 2BB
Cyclophosphamide
Masonic Cancer Center, University of Minnesota
Phase 2B

View all 14 →

Same molecule, other indications

Rimiducid is also rated in:

myelodysplastic syndromeDormant
CCC
Indicative ·
51 / 100
View asset →
inborn error of immunityDormant
CCC
Indicative ·
50 / 100
View asset →
myeloproliferative neoplasmDormant
CCC
Indicative ·
50 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →